Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Total Liabilities (2022 - 2025)

Praxis Precision Medicines has reported Total Liabilities over the past 4 years, most recently at $59.8 million for Q4 2025.

  • Quarterly results put Total Liabilities at $59.8 million for Q4 2025, up 58.71% from a year ago — trailing twelve months through Dec 2025 was $59.8 million (up 58.71% YoY), and the annual figure for FY2025 was $59.8 million, up 58.71%.
  • Total Liabilities for Q4 2025 was $59.8 million at Praxis Precision Medicines, up from $52.9 million in the prior quarter.
  • Over the last five years, Total Liabilities for PRAX hit a ceiling of $59.8 million in Q4 2025 and a floor of $18.3 million in Q4 2023.
  • Median Total Liabilities over the past 4 years was $35.8 million (2023), compared with a mean of $36.0 million.
  • Biggest five-year swings in Total Liabilities: crashed 53.16% in 2023 and later soared 121.32% in 2025.
  • Praxis Precision Medicines' Total Liabilities stood at $39.0 million in 2022, then tumbled by 53.16% to $18.3 million in 2023, then surged by 106.03% to $37.7 million in 2024, then soared by 58.71% to $59.8 million in 2025.
  • The last three reported values for Total Liabilities were $59.8 million (Q4 2025), $52.9 million (Q3 2025), and $48.6 million (Q2 2025) per Business Quant data.